SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential as an AI automation leader, especially after recent partnerships with major tech companies. The community is drawing comparisons to Palantir ($PLTR) and anticipating a possible gamma squeeze, fueled by high short interest. Some are noting the stock's long consolidation period and suggesting a significant breakout may be imminent, while others are wary of its high P/E ratio.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices approach levels not seen in over a decade, sparking discussions about a potential breakout. Community members are actively debating whether this rally has legs, some citing industrial demand and a weaker dollar, while others express caution about a possible pullback. The ETF's movements are also being scrutinized relative to the spot price of silver, fueling speculation about market manipulation and short squeezes.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

Gold is trending as it nears all-time highs, fueled by concerns over government shutdowns and broader economic uncertainty, with some analysts predicting further gains. Community discussions highlight gold's role as a safe haven asset amidst a weakening dollar, sparking debates on whether it's currently overbought or undervalued. The metal's surge is also drawing comparisons to other asset classes like equities and crypto, with some suggesting a potential rotation of funds into gold.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending due to a newly announced partnership focused on developing quantum-resistant chips for defense applications, sparking excitement around its potential role in securing sensitive infrastructure. Community members are actively discussing the potential for a short squeeze and comparing it to other trending quantum computing stocks. Some are noting the connection to $WKEY, its majority owner, and speculating on future price targets amid high trading volume.

Global Health Solutions Inc is an American company that works with partners to eliminate diseases that have plagued humanity for centuries and protect the health of populations by helping countries build strong health systems. The private company is located in the US. The company brings together key stakeholders around the world with a common goal to stop diseases and strengthen health systems through powerful partnerships. The company consists of programs and focus areas that cover a range of health issues including neglected tropical diseases, infectious diseases, vaccines, field epidemiology, public health informatics, health workforce development, and health ethics. The company's end goal is to eliminate diseases and protect the health of populations.

Turn Therapeutics Inc.

Turn Therapeutics Inc

Turn Therapeutics ($TTRX) is trending due to significant volatility following its IPO, with the community debating its valuation and potential for short squeezes. Traders are actively discussing its high short interest and comparing it to other recent high-flying biotech stocks, while also weighing the risks of a potential pullback. The stock's unusual price action and halt events are fueling speculation and trading activity.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending as the community discusses a potential short squeeze amid high short interest and recent price movements. Community members are also speculating about potential buyout rumors and the company's upcoming catalysts, including patent extensions and EPA approval. Discussions also include recent insider buying and analyst price targets.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending amid excitement surrounding its upcoming Kraken listing on October 15th, which the community sees as a major milestone and a gateway for wider adoption. Discussions also revolve around potential future listings on Coinbase and Binance, as well as the upcoming SuperApp. Community members are sharing bullish sentiments and expressing optimism about the project's long-term potential in the blockchain payment space.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending as community members discuss the potential of their sublingual film technology, particularly Anaphylm for severe allergic reactions, following recent positive media attention. The stock's momentum is fueled by anticipation of the FDA decision in early 2026, with many longs expressing confidence in the company's prospects. Bullish investors are hopeful for a buyout and believe approval of Anaphylm will cause the stock to soar.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending as investors discuss its potential following a recent partnership with DoorDash to expand autonomous delivery. While some express concerns about high operating costs and revenue, others highlight the company's strong position in the robotics sector and potential for growth. Community members are actively analyzing the chart, with some anticipating a continued uptrend and potential breakout.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as traders discuss potential breakouts and reversals, with many pointing to bullish chart signals. Community members are also closely watching the stock in relation to upcoming earnings reports from major tech companies. Additionally, Google's advancements in AI, including Gemini, are generating buzz and influencing investor sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A Look Ahead: Apyx Medical's Earnings Forecast

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Renuvion Named #1 Trusted Body Contouring Technology by Doctors* Renuvion Named #1 Trusted Body Contouring Technology by Doctors* PR Newswire CLEARWATER, Fla., Aug. 13, 2024 Independent survey...

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Apyx Medical Corporation (NASDAQ:APYX) (Apyx Medical; the Company), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion, today...

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Apyx Medical Corporation (NASDAQ:APYX) (the Company), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion, today announced that...

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

Apyx Medical Corporation Launches the 'Renewing Lives' Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health Apyx Medical Corporation Launches the...

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

Apyx Medical Corporation (NASDAQ:APYX) (Apyx Medical; the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today reported...

Apyx Medical Corporation Announces Board Leadership Transition

Apyx Medical Corporation (NASDAQ:APYX) (Apyx Medical; the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced the...

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apyx Medical Corporation (NASDAQ:APYX) (the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced that financial...

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion Users Summit

Apyx Medical Corporation (NASDAQ:APYX) (the Apyx Medical; Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, is pleased to announce...

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacturer (OEM). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Apyx Medical Corp

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$2.96
Prev Close	$2.87
Open	$2.86
Dividend Yield	0.00%
50-Day Moving Average	$2.12
Beta	0.38
Avg. Volume	62,254.57
PE Ratio	-6.36

52-Week High	$2.99
52-Week Low	$0.7554
Market Capitalization	$108.54M
EPS (Annual)	-$0.6602
Price to Book	14.95
Revenue Per Employee	$218,645.45
Enterprise Value/EBITDA	N/A

APYX
Apyx Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APYX News

APYX Apyx Medical Corp